AzTrials
AzTrials

Proximal Humeral FractureNCT03498859

Efficacy of Physiotherapist-supervised Rehabilitation After Proximal Humerus Fracture

A study testing Physiotherapist-supervised training and Home-based training in people with Proximal Humeral Fracture, run by University of Aarhus at 2 sites in 2 countries.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study investigates the efficacy of physiotherapist-supervised training once per week during 10 weeks compared to home-based training during 10 weeks, after proksimal humerus fracture. Read more about this study

Who is it for?
Ages 60 years and older
Conditions the study is for
Proximal Humeral Fracture
What is being tested?
Physiotherapist-supervised training and Home-based training
Could I receive a placebo?
No, everyone receives an active treatment
How many people
70 participants
Where
2 sitesin 2 countries
Study dates
24 Apr 2018to 25 Jan 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 60 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • •Low energy proximal humeral displaced (more than 5mm or 30 degrees) two-part fracture where fracture line emerges through the surgical (or anatomical) neck, treated non-operatively

Who cannot join

  • Refuse to participate in the study
  • Younger than 60 years old
  • Non-independent
  • Demented
  • Does no understand written and spoken guidance in local language
  • Pathological fracture or previous fracture in the same proximal humerus
Show all 15Show fewer
  • Other operational injuries in the same upper limb
  • Major nerve injury (e.g. Complete radialis- or delta palsy)
  • Open fracture
  • Multi-trauma patient
  • Fracture dislocation or head splitting fracture
  • Undisplaced fracture
  • Isolated tuberculum fracture
  • Fracture has no precondition to ossify by conservative treatment (no bony contact between fracture parts or the humeral shaft is in contact with the articular surface)
  • Treating surgeon considers patient unsuitable to attend the study on medical basis

Trial locations and contacts

2 sites in 2 countries.

2 sites in 2 countries

Denmark1 site
  • Viborg Regional Hospital

    Viborg, 8800

Other trials in Denmark

Norway1 site
  • Oslo University Hospital

    Oslo

Other trials in Norway

About this study

Official title: Efficacy of Physiotherapist-supervised Rehabilitation After Two-part Proximal Humerus Fractures Treated Non-operatively. A Randomised Controlled Trial

This study investigates the efficacy of physiotherapist-supervised training once per week during 10 weeks compared to home-based training during 10 weeks, after proksimal humerus fracture.

Read the detailed description

Proximal humerus fracture is the third most common fracture in elderly people after hip and colles fracture, and are often caused by fall and osteoporosis. These fractures are highly related to morbidity and mortality among elderly people and consumes considerably health care resources. More than 70% of the proximal humerus fracture patients are over 60 years of age and 75% are female.

Only sparse evidence reveals to what extend the patients need rehabilitation and how it should be implemented in the treatment strategy.

In Denmark as well as in Finland the rehabilitation after proximal humerus fractures takes place in local centers in the municipalities, and the rehabilitation offered to the patients varies significantly. Currently in Denmark there are no national clinical guidelines to support the rehabilitation strategy.

Being tested
Physiotherapist-supervised training, Home-based training
Keywords
Rehabilitation
Medical subject headings
Shoulder Fractures

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Physiotherapist-supervised trainingOther

    The intervention is physiotherapist-supervised training once per week during 10 weeks.

  • Home-based trainingOther

    The intervention is home-based training during 10 weeks

Study groups in NCT03498859
Study groupRoleWhat they receive
Home-based trainingOther10 weeks of home-based training with no supervision of a physiotherapist
Receives: Other: Home-based training
Physiotherapist-supervised trainingOtherPhysiotherapist-supervised training once per week during 10 weeks in addition to home-based training
Receives: Other: Physiotherapist-supervised training

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The Disability of the Arm, Shoulder and Hand (DASH)

    Patient reported outcome measure of physical function in the upper extremity. Measures on a 0-100 scale, where a higher score indicates greater disability.

    The scores will be compared between the 2 groups

    Measured: Measured at 3 months after fracture

Secondary outcomes (6)
  1. The Disability of the Arm, Shoulder and Hand (DASH)

    Patient reported outcome measure of physical function in the upper extremity. Measures on a 0-100 scale, where a higher score indicates greater disability.

    The scores will be compared between the 2 groups

    Measured: Measured at baseline and after 12 months

  2. Constant Murley Shoulder Score

    Subjective and objective measurement of the shoulder function. Measures on a 0-100 scale, where a lower score indicates greater disability. The scores will be compared between the 2 groups

    Measured: Measured after 3 and 12 months.

  3. 15-dimentional health-realted quality of life instrument (15D)

    Patient reported outcome measure of health related quality of life. A set of utility or preference weights is used to generate the 15D score (single index number) on a 0-1 scale, where a higher score indicates a poor health related quality of life.

    The scores will be compared between the 2 groups

    Measured: Measured at baseline, after 3 and 12 months

  4. Pain catastrophizing Scale

    Patient reported outcome measure. Measures on a 0-53 scale, where a higher score indicates a higher levels of pain catastrophizing thinking.

    The scores will be compared between the 2 groups. Also the correlation with DASH scores will be investigated

    Measured: Measured at baseline, after 3 and 12 months

  5. Generel Self-Efficacy scale

    Patient reported outcome measure. Measures on a 10-40 scale, where a higher score indicates a higher degree of self-efficacy.

    The scores will be compared between the 2 groups. Also the correlation with DASH scores will be investigated

    Measured: Measured at baseline, after 3 and 12 months

  6. Accelerometer based activity in the upper extremity

    The patient is wearing a censor above the elbow on both arms, that measures the level of upper extremity activity for three consecutive days. It measures the number of movements under and above shoulder hight and classify them into either high or low intensity movements.

    The asymmetry between the fractured and the healthy arm will be estimated and compared between the groups.

    Measured: Measured at 3 and 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Apr 2018
  2. Study start24 Apr 2018
  3. Primary completion25 Jan 2022
  4. Study completion25 Jan 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
70 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03498859
Sponsor's protocol ID
ProxHumRehab
Status last verified
Dec 2022
First submitted
3 Apr 2018
Last updated
5 Jan 2023
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Handoll HH, Elliott J, Thillemann TM, Aluko P, Brorson S. Interventions for treating proximal humeral fractures in adults. Cochrane Database Syst Rev. 2022 Jun 21;6(6):CD000434. doi: 10.1002/14651858.CD000434.pub5.

    PubMed 35727196

Questions about this trial

What is this clinical trial studying?

A study testing Physiotherapist-supervised training and Home-based training in people with Proximal Humeral Fracture, run by University of Aarhus at 2 sites in 2 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 15 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 5 Jan 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Denmark, Norway. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The Disability of the Arm, Shoulder and Hand (DASH) (time frame: Measured at 3 months after fracture). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03498859, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Jan 2023; AzTrials last refreshed its copy on 8 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in